The ®rst step in kidney development is the formation of the pronephros which is derived from mesoderm. Xenopus is an appropriate model to study this process since the pronephros can be ef®ciently induced in animal cap explants by treatment with activin and retinoic acid (RA). Using this in vitro system, we isolated a Xenopus homologue of SMP-30 (Senescence marker protein-30), which is a Ca 21 -binding protein that is highly conserved in vertebrates. This gene, termed XSMP-30, was found to be selectively expressed in pronephric tubules from the late tadpole stage, by whole mount in situ hybridization. Furthermore XSMP-30 was expressed in animal caps treated with both activin and RA, a condition in which the pronephros is formed in vitro. These data indicate that XSMP-30 is a speci®c marker for the pronephros. q
Results
In vertebrates, kidney development involves the progressive development of three structures; the pronephros, mesonephros and metanephros. Advances in gene targeting in mice have identi®ed several genes that function in the pathway of kidney development, most of which are involved in metanephros formation. Xenopus provides a suitable model to study the earlier steps of kidney formation, including the induction of the pronephros from mesoderm. Treatment of Xenopus animal caps with activin and retinoic acid (RA) can ef®ciently induce pronephros formation (Moriya et al., 1993; Uochi and Asashima, 1996) .
To isolate genes expressed in pronephric development, we constructed a library from animal caps which were treated with activin (10 ng/ml) and RA (10 24 M) for 3 h and then cultured for 3 days. We then subtracted an unfertilized egg library from the animal cap library and the expression pattern of clones in the subtracted library was analyzed using whole mount in situ hybridization. Two clones were expressed in pronephric tubules in early Xenopus embryos, which were homologous to Senescence Marker Protein-30 (SMP-30), already cloned in other vertebrates (Fujita, 1999; Murata and Yamaguchi, 1999) . Therefore we named this gene XSMP-30. The XSMP-30 cDNA encodes 299 amino acids and has 84% identity to its mouse and human counterparts (Fig. 1) . One of the two clones contained the full length cDNA, and the other lacked the 5 H terminal region. Mammalian SMP-30 shows decreased expression in aging rats and is identical to the Ca 21 -binding protein called Regucalcin (RC). In the mouse, it is present in the cytoplasm and has effects on activation and inhibition of various Ca 21 -dependent enzymes. To investigate the detailed pattern of expression of XSMP-30, we made use of whole mount in situ hybridization. XSMP-30 was expressed selectively in pronephric tubules, and not in pronephric ducts, from the late tadpole stage (Fig. 2A±C) , well after the pronephros is formed. In a transverse section, we con®rmed that it was only expressed in pronephric tubules (Fig. 2D ). We observed no signals outside of pronephric tubules at any developmental stage (data not shown). This pattern of XSMP-30 expression is unique, as other molecules reported to be expressed in the pronephros are also detected in other regions. Therefore XSMP-30 is a speci®c marker for the pronephros.
Synergism between Xlim-1 and XPax-8 may well be a key early step in establishment of the pronephric primordium (Carroll and Vize, 1999) . Therefore, we compared the expression of XSMP-30, XPax-8 and Xlim-1 during devel-opment (Fig. 3A) . Xlim-1 is expressed from st. 10 and XPax-8 from st. 12.5 (Taira et al., 1994; Heller and Brandli, 1999) , which is consistent data given in Fig. 3A . The expression of XSMP-30 started from a relatively late stage (st. 32), and was consistent with the results of whole mount in situ hybridization. We next examined the expression of these markers in animal caps induced to form pronephric tubules in vitro. XSMP-30 was highly expressed in animal caps treated with activin and RA for 3 h and cultured for 3 days, treatment which leads to pronephros formation (Fig.  3B) . Activin alone induced XSMP-30 much less ef®ciently in animal caps. Xlim-1 was expressed in animal caps treated with activin or RA alone for 3 h. XPax-8 was expressed in animal caps treated with activin alone for 24 h. As both XPax-8 and Xlim-1 are expressed in multiple tissues, the RT-PCR bands in Fig. 3B may re¯ect this additional expression, as well as pronephric expression. Compared with the early expression of Xlim-1 and XPax-8, XSMP-30 is considered to be a marker for the late stage of the pronephros.
Methods

Library subtraction
A Time Saver cDNA synthesis kit (Pharmacia) was used to generate a cDNA library from approximately 1000 animal pole explants harvested 72 h after treatment with 10 ng/ml activin A (provided by Dr. Y. Eto, Ajinomoto Co., Japan) and 10 24 M retinoic acid for 3 h. The cDNA inserts were cloned into an EcoRI-NotI digested pBluescript II KS (2) plasmid (Stratagene). A second library was generated from unfertilized Xenopus egg, the inserts of which were cloned into an EcoRI-NotI digested RN3 plasmid (Lemaire et al., 1995) .
The subtraction procedure used was as described (Hara et al., 1994; Nishinakamura et al., 1997) . Brie¯y, both libraries were digested with EcoRI and NotI. The tracer library and biotinylated driver library were both denatured and hybridized. The hybridized double-stranded DNA was removed by phenol-chloroform extraction and the tracer-speci®c DNA was ligated into a PCR II (Invitrogen) vector, as a subtracted library. 
Whole mount in situ hybridization
The whole mount in situ hybridization procedure used was as described (Harland, 1991) . The XSMP-30 antisense probe was transcribed with T7 RNA polymerase from the entire cDNA clone in PCR II. The sense probe gave no signal (data not shown).
RT-PCR
Total RNA from whole embryos and animal cap explants was isolated using TRIzol Reagent (Gibco-BRL) and 1 mg of total RNA was used for RT-PCR. Primers used in this study were as follows:
² XSMP-30 (f, TTAGACTGGTCTCTGGATCAC; ² r, CGATAGGTAACTTTACAGTCTG) (262 bp), ² XPax-8 (f, TCAGCTCAGGATGCTCAGC; ² r, GCTGTAGTAATAGGGAGAGC) (290 bp), ² Xlim-1 (f, AAGACTCTGAAAGTGCCAATG; ² r, AGTCTGAGCTTGAGACGATG) (461 bp), ² ornithine decarboxylase (ODC) ² (f, GTCAATGATGGAGTGTATGGATC; ² r, AGGTAAGGCGAGAGGACTCGTG).
RT-PCR assays were done in the exponential phase of ampli®cation. In each RT(2) control in Fig. 3A ,B, we used total RNA from st. 40 embryo and animal caps treated with activin and RA, cultured for 72 h. 
